In California, a new report “Analysis of Biomedical Textiles Market in U.S.” from Frost & Sullivan’s Visionary Science Team predicts a growth in the use of biomaterials, especially those that biodegrade, in medical device implants. The report notes that with an increasing geriatric population who are more likely to have chronic illnesses and longer recovery times, this is a huge step forward as they will now be less likely to need a second surgery to remove implants. The increases in demand for biodegradable implants are leading to more market innovation and new product launches to improve upon existing technologies and biomaterial applications. Some companies that are leading this work right now to keep an eye on include Boston Scientific, CR Bard, Smith and Nephew, Medtronic and Edwards Lifesciences.
Latest article
Not PLA‑ying dead: Bioplastic skulls replace gory antler mounts
In Utah, Bucks N Bull Skulls is using bioplastic polylactic acid filament to 3-D print animal skulls for mounting antlers – an alternative that...
Funding flatlines: Meatable closes up shop
In the Netherlands, cultivated meat pioneer Meatable has failed to secure sufficient funding and is winding down operations. The company had been operating a...
“Sound” investment: Biobased acoustic panel maker Aisti receives €20 million EIB loan
In Finland, sustainable acoustics products firm Aisti has received a €20 million (US$23.4 million) loan from the European Investment Bank to scale production of...